JP Morgan Maintains Overweight on Glaukos, Raises Price Target to $140

Benzinga Newsdesk www.benzinga.com Positive 53.4%

Neg 0% Neu 0% Pos 53.4%

JP Morgan analyst Allen Gong maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $120 to $140.